Redmile Group’s AtriCure ATRC Stock Holding History

Redmile Group’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-325,000	Closed	-$8.71M	–	85
2019 Q1	$8.71M	Buy	325,000 +25,000	+8%	+$759K	0.25%	59
2018 Q4	$9.18M	Buy	+300,000	New	+$9.35M	0.37%	53

Other funds holding ATRC

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Redmile Group's ATRC Position: Q2 2019 in Review

Redmile Group sold out of AtriCure (ATRC) in Q2 2019, closing a stake of 325,000 shares — an estimated $8.71M sold.

Redmile Group first reported a position in ATRC in Q4 2018 and held it in 2 quarters. The position peaked at $9.18M in Q4 2018. 145 funds tracked by Wall St. Rank hold ATRC as of Q2 2019.

Redmile Group reported no remaining AtriCure position as of Q2 2019 after selling out during the quarter.
Redmile Group sold 325,000 AtriCure shares in Q2 2019, an estimated $8.71M.
Redmile Group first reported a position in AtriCure in Q4 2018 and held it in 2 quarters.
Redmile Group's AtriCure position peaked at $9.18M in Q4 2018.
145 funds tracked by Wall St. Rank held AtriCure as of Q2 2019.

Based on Redmile Group's 13F filing for Q2 2019, filed 14 Aug 2019.